Xenygloxal

This classification denotes an antiviral agent and antimicrobial with the molecular formula C16H10O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3C2T3HG40E, chemically known as 4,4-diphenyldicarboxaldehyde but generally known as xenygloxal, which bears US NIH Compound Identifier 239061. European Medicines Agency schedules Xenygloxal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00106MIG. The term XENYGLOXAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). XENYGLOXAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule xenygloxal under HS 29144090 and SITC 51629. As of Q4 2014, XENYGLOXAL remains the US FDA Preferred Term for this commodity. Xenygloxal bears US NLM identifiers UMLS ID C1883575 and NCI Concept Code C66666. SMILES: O=C(C1CCC(C2CCC(CC2)C(=O)C=O)CC1)C=O.